Clinical Trial

Relationship Between Metrnl Expression, IL-1β, and TNF-α in Patients With Peri-Implantitis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 13, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Peri-implantitis is an inflammatory disease affecting the tissues around dental implants and may lead to progressive bone loss and implant failure. Current diagnosis is mainly based on clinical and radiographic findings, which may not fully reflect the underlying inflammatory activity. Therefore, there is a need for biological markers that may provide additional information about disease-related changes. This observational study aims to compare the levels of Meteorin-like protein (Metrnl) and selected inflammatory cytokines in peri-implant crevicular fluid obtained from individuals with peri-implantitis and individuals with healthy implants. The study will evaluate Metrnl, interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-10 (IL-10). It will also examine the relationships between Metrnl and these inflammatory markers. The study hypothesis is that Metrnl levels differ between healthy peri-implant tissues and peri-implantitis and are associated with pro-inflammatory and anti-inflammatory cytokine levels. The findings may help clarify the possible role of Metrnl in peri-implant inflammation and its potential as a biomarker for distinguishing peri-implant health from peri-implantitis.
Trial Details
NCT Number NCT07697729
Lead Sponsor Ataturk University
Conditions Peri-implantitis
Enrollment 60 participants
Start Date 2026-07-07
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-13